BibTex RIS Cite

Primary pericardial malignant mesothelioma: A rare but aggressive disease

Year 2012, Volume: 34 Issue: 1, 94 - 97, 27.03.2012

Abstract

Abstract

Malignant mesothelioma of the pericardium is a rare disorder with a worse outcome compared to the pleural presentation of the disease. All treatment modalities are usually palliative. Here we report a patient with malignant mesothelioma of the pericardium presenting with severe dyspnea and pericardial effusion who survived only 2 months despite aggressive treatment.

Keywords: Malign mesothelioma; pericardium; chemotherapy

 

Özet

Malign perikardiyal mezotelyoma plevral mezotelyoma ile karşılaştırıldığında nadir ve daha kötü seyirli bir hastalıktır. Tüm tedavi uygulamaları genellikle palyatif kalmaktadır. Bu makalede ciddi dispne ve perikardiyal effüzyon ile seyreden ve agresif tedaviye rağmen sadece 2 ay yaşayabilen bir malign perikardiyal mezotelyoma olgusu sunulmaktadır.

Anahtar sözcükler: Malign mezotelyoma; perikard; kemoterapi

References

  • Kralstein J, Frishman W. Malignant pericardial diseases: diagnosis and treatment. Am Heart J 1987; 113: 785-90.
  • Vornicu M, Arora S, Achilleos A. Primary pericardial mesothelioma: a rare cardiac malignancy. Internal Medicine Journal 2007; 37: 576-7.
  • Santos C, Montesinos J, Castaner E, Sole JM, Baga R. Primary pericardial mesothelioma. Lung Cancer 2008; 60: 291-3.
  • Gössinger HD, Siostrzonek P, Zangeneh M, Neuhold A, Herold C, Schmoliner R, Laczkovics A, Tscholakoff D, Mösslacher H. Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J 1988; 115: 1321- 2.
  • Papi M, Genestreti G, Tassinari D, Lorenzini P, Serra S, Ricci M, Pasquini E, Nicolini M, Pasini G, Tamburini E, Fattori PP, Ravaioli A. Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis. Tumori 2005; 91: 276-9.
  • Small GR, Nicolson M, Buchan K, Broadhurst P. Pericardial malignant mesothelioma: a latent complication of radiotherapy? Eur J Cardiothorac Surg 2008; 33: 745-7.
  • Nilsson A, Rasmuson T. Primary pericardial mesothelioma: report of a patient and literature review. Case rep Oncol 2009; 2: 125-32.
  • Rose DS, Vigneswaran WT, Bovill BA, Riordan JF, Sapsford RN, Stanbridge RD. Primary pericardial mesothelioma presenting as tuberculous pericarditis. Postgrad Med J 1992; 68: 137-9.
  • Vigneswaran WT, Stefanacci PR. Pericardial mesothelioma. Curr Treat Options Oncol 2000; 1: 299-302.
  • Nambiar CA, Tareif HE, Kishore KU, Ravindran J, Banerjee AK. Primary pericardial mesothelioma: one-year event-free survival. Am Heart J 1992; 124: 802-3.
  • Maruyama R, Sakai M, Nakamura T, Suemitsu R, Okamoto T, Wataya H, Nishiyama K, Kamei T, Ichinose Y. Triplet chemotherapy for malignant pericardial mesothelioma: A case report. Jpn J Clin Oncol 2006; 36: 245-8.
  • Maisch B, Ristić AD, Pankuweit S, Neubauer A, Moll R. Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 2002; 23: 1625-31.

Primary pericardial malignant mesothelioma: A

Year 2012, Volume: 34 Issue: 1, 94 - 97, 27.03.2012

Abstract

Malign perikardiyal mezotelyoma plevral mezotelyoma ile karşılaştırıldığında nadir ve daha kötü seyirli bir hastalıktır. Tüm tedavi uygulamaları genellikle palyatif kalmaktadır. Bu makalede ciddi dispne ve perikardiyal effüzyon ile seyreden ve agresif tedaviye rağmen sadece 2 ay yaşayabilen bir malign perikardiyal mezotelyoma olgusu sunulmaktadır

References

  • Kralstein J, Frishman W. Malignant pericardial diseases: diagnosis and treatment. Am Heart J 1987; 113: 785-90.
  • Vornicu M, Arora S, Achilleos A. Primary pericardial mesothelioma: a rare cardiac malignancy. Internal Medicine Journal 2007; 37: 576-7.
  • Santos C, Montesinos J, Castaner E, Sole JM, Baga R. Primary pericardial mesothelioma. Lung Cancer 2008; 60: 291-3.
  • Gössinger HD, Siostrzonek P, Zangeneh M, Neuhold A, Herold C, Schmoliner R, Laczkovics A, Tscholakoff D, Mösslacher H. Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J 1988; 115: 1321- 2.
  • Papi M, Genestreti G, Tassinari D, Lorenzini P, Serra S, Ricci M, Pasquini E, Nicolini M, Pasini G, Tamburini E, Fattori PP, Ravaioli A. Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis. Tumori 2005; 91: 276-9.
  • Small GR, Nicolson M, Buchan K, Broadhurst P. Pericardial malignant mesothelioma: a latent complication of radiotherapy? Eur J Cardiothorac Surg 2008; 33: 745-7.
  • Nilsson A, Rasmuson T. Primary pericardial mesothelioma: report of a patient and literature review. Case rep Oncol 2009; 2: 125-32.
  • Rose DS, Vigneswaran WT, Bovill BA, Riordan JF, Sapsford RN, Stanbridge RD. Primary pericardial mesothelioma presenting as tuberculous pericarditis. Postgrad Med J 1992; 68: 137-9.
  • Vigneswaran WT, Stefanacci PR. Pericardial mesothelioma. Curr Treat Options Oncol 2000; 1: 299-302.
  • Nambiar CA, Tareif HE, Kishore KU, Ravindran J, Banerjee AK. Primary pericardial mesothelioma: one-year event-free survival. Am Heart J 1992; 124: 802-3.
  • Maruyama R, Sakai M, Nakamura T, Suemitsu R, Okamoto T, Wataya H, Nishiyama K, Kamei T, Ichinose Y. Triplet chemotherapy for malignant pericardial mesothelioma: A case report. Jpn J Clin Oncol 2006; 36: 245-8.
  • Maisch B, Ristić AD, Pankuweit S, Neubauer A, Moll R. Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 2002; 23: 1625-31.
There are 12 citations in total.

Details

Primary Language English
Journal Section Case Reports
Authors

Çağatay Arslan

Saadettin Kılıçkap

Alev Türker

Publication Date March 27, 2012
Published in Issue Year 2012Volume: 34 Issue: 1

Cite

AMA Arslan Ç, Kılıçkap S, Türker A. Primary pericardial malignant mesothelioma: A rare but aggressive disease. CMJ. March 2012;34(1):94-97.